Health2Sync Of Taiwan Raises $3 Million For Mobile Diabetes Monitoring

Health2Sync, a Taiwan medical device company, secured $3 million in a Series A for its mobile diabetes monitoring platform. The company plans to expand into Japan, China and Southeast Asia. Health2Sync says its device shows diabetes patients how foods affect their blood sugar levels. Using its system for 120 days, patients were able to lower their average HbA1c from 8.60% to 6.89%. The investment was led by WI Harper Group and joined by other investors with an interest in China.